7% CAGR Is Marked In Induced Pluripotent Stem Cells Market With The Value of US$ 17,200 Mn By 2026
The healthcare industry has been focusing on excessive research and development in the last couple of decades to ensure that the need to address issues related to the availability of drugs and...